The much publicized Healthcare reform in the USA has taken its effect on the industry. Job losses are ripping through the heart of America and continuing government pressure to improve systems to deal with President Barack Obama's changes brings their own challenges, so leading health care executives met at the NG Healthcare Summit last week in Dallas, Texas, to discuss the issues.
The USA spends around $2,000 billion a year on health care expenses, more than any other country across the globe, but critics are still questioning if the country's finances will be able to support the reform. Despite original predictions that costs would be reduced it would do little to stem healthcare expenditure, something which executives from the industry are determined not to let happen.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze